| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |